NOVO.B.DK

226.85

-5.34%↓

GMAB.DK

1,690

+0.12%↑

HLUNB.DK

38.62

0%↓

ZEAL.DK

283.1

-2.98%↓

AMBUB.DK

67.55

-2.81%↓

NOVO.B.DK

226.85

-5.34%↓

GMAB.DK

1,690

+0.12%↑

HLUNB.DK

38.62

0%↓

ZEAL.DK

283.1

-2.98%↓

AMBUB.DK

67.55

-2.81%↓

NOVO.B.DK

226.85

-5.34%↓

GMAB.DK

1,690

+0.12%↑

HLUNB.DK

38.62

0%↓

ZEAL.DK

283.1

-2.98%↓

AMBUB.DK

67.55

-2.81%↓

NOVO.B.DK

226.85

-5.34%↓

GMAB.DK

1,690

+0.12%↑

HLUNB.DK

38.62

0%↓

ZEAL.DK

283.1

-2.98%↓

AMBUB.DK

67.55

-2.81%↓

NOVO.B.DK

226.85

-5.34%↓

GMAB.DK

1,690

+0.12%↑

HLUNB.DK

38.62

0%↓

ZEAL.DK

283.1

-2.98%↓

AMBUB.DK

67.55

-2.81%↓

Search

Coloplast A-S (Class B)

Deschisă

430.3 -1.78

Rezumat

Modificarea prețului

24h

Curent

Minim

430.6

Maxim

439.7

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.382

57.05

EPS

6.32

Randament dividend

5.47

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.47%

2.52%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

97B

Deschiderea anterioară

432.08

Închiderea anterioară

430.3

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 mar. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

26 mar. 2026, 23:36 UTC

Market Talk
Evenimente importante

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

26 mar. 2026, 23:35 UTC

Achiziții, Fuziuni, Preluări

Pernod Ricard: Confirms Discussions With Brown-Forman

26 mar. 2026, 23:29 UTC

Câștiguri

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

26 mar. 2026, 23:28 UTC

Câștiguri

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

26 mar. 2026, 23:27 UTC

Câștiguri

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

26 mar. 2026, 23:27 UTC

Câștiguri

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

26 mar. 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

26 mar. 2026, 23:04 UTC

Achiziții, Fuziuni, Preluări

Pernod in Deal Talks With Brown-Forman -- WSJ

26 mar. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

26 mar. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

26 mar. 2026, 22:26 UTC

Câștiguri

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

26 mar. 2026, 22:08 UTC

Câștiguri

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

26 mar. 2026, 22:07 UTC

Market Talk
Evenimente importante

Global Energy Roundup: Market Talk

26 mar. 2026, 22:07 UTC

Market Talk
Evenimente importante

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

26 mar. 2026, 22:00 UTC

Câștiguri

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

26 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

26 mar. 2026, 21:38 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat